Anandamide, Not Endorphins: How the Endocannabinoid System Drives the Runner's High

The blood-brain barrier operates as a strict, non-negotiable filtration system for the central nervous system, deciding exactly which molecules are permitted to enter the brain and alter a runner's mental state. For decades, athletes and coaches assumed that this barrier routinely admitted beta-endorphins—the body's natural painkillers—during a long run, rewarding the effort with a wave of euphoria. But the barrier's actual physical constraints tell a different story. Endorphins are large, hydrophilic peptides. When a runner hits the pavement, the barrier physically blocks these bulky molecules from crossing over from the bloodstream into the brain.[4]

Instead, the barrier readily admits a different class of molecules: endocannabinoids. These are small, lipid-based neurotransmitters that the body produces naturally, and they are structurally built to slip right through the brain's defenses. The most prominent of these is arachidonoyl ethanolamide, commonly known as anandamide, which was first discovered in 1992. Named after the Sanskrit word for bliss, anandamide binds to the exact same CB1 and CB2 receptors as the active compounds found in the cannabis plant.[2][3]

The shift in scientific consensus fundamentally changes how sports medicine practitioners view the mental health benefits of running. Davy Phrathep, a sports and performance psychologist at Johns Hopkins All Children's Hospital, notes that while endorphins do spike in the bloodstream to help blunt localized muscle pain, they are not the architects of the mental shift. "Although endorphins help reduce pain during exercise, it is unlikely that endorphins alone are responsible for the euphoric feeling known as the runner's high," Phrathep explains.[3]

To trigger this endocannabinoid release, the body requires a specific metabolic commitment. Stefanie Klozik, a physical therapist and athletic trainer at the Henry Ford Center for Athletic Medicine, points out that a quick 15-minute jog around the block is rarely enough to flood the system with anandamide. Runners typically need to sustain 30 to 60 minutes of continuous, moderate-intensity aerobic exercise—often defined as maintaining a heart rate between 70 and 80 percent of maximum—before the endocannabinoid system fully activates.[4]

"Endorphins flood your bloodstream during exercise, but they're too large to cross the blood-brain barrier easily," Klozik says. "Endocannabinoids, however, easily cross this barrier, allowing them to affect your brain and nervous system. Some people notice mental clarity, less anxiety and lower pain perception."[4]

The evidence supporting the endocannabinoid hypothesis solidified significantly following a landmark 2015 study published in Volume 112 of the Proceedings of the National Academy of Sciences. Researchers led by Johannes Fuss demonstrated that when mice were given free access to running wheels for 6 hours, their endocannabinoid levels reliably increased, which directly correlated with reduced anxiety and a higher tolerance for pain.[5]

Crucially, the 2015 study proved the mechanism by selectively blocking specific receptors. When the researchers chemically blocked the mice's opioid receptors, the animals still experienced the calming, pain-relieving benefits of the run. However, when they blocked the cannabinoid receptors, those benefits vanished entirely. This confirmed that an intact endocannabinoid system—not the opioid system—was the indispensable engine behind the runner's high.[1][5]

For everyday runners, this biological reality offers a highly practical blueprint for managing mental health. Because anandamide works in tandem with dopamine to reinforce rewarding behaviors, the brain is actively chemically incentivizing the runner to repeat the 45-minute aerobic effort. It frames the runner's high not as a mystical, unpredictable event, but as a reliable physiological response to a specific dose of cardiovascular work.[4][6]

However, the endocannabinoid system is highly sensitive to overall physiological stress. Klozik warns that overtraining or under-fueling can actively suppress the release of anandamide. "If you train so hard that you use up your available energy, your body will pause some of its jobs, including your endocannabinoid response," she notes.[4]

This means that chasing the runner's high requires a balanced approach to pacing and recovery. Pushing into the anaerobic zone—where the heart rate spikes above 85 percent of its maximum—shifts the body's priorities toward immediate survival and lactate clearance, rather than the synthesis of lipid-based neurotransmitters. The sweet spot remains a steady, conversational pace maintained for at least half an hour.[2][3]

Understanding that anandamide drives the runner's high demystifies the experience. It reassures runners that if they do not feel a wave of euphoria during a grueling interval session, their brain chemistry is not broken; they simply have not provided the sustained aerobic stimulus required to unlock the blood-brain barrier. The next time a runner laces up their shoes, the objective is not to chase a mythical endorphin rush, but to settle into a 45-minute rhythm that allows the body's own lipid molecules to quietly cross into the brain.[6]